Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-02-20 @ 12:47 PM
Study NCT ID:
NCT02501551
Status:
UNKNOWN
Last Update Posted:
2021-04-05
First Post:
2015-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02
Start Date Type:
None
Primary Completion Date:
2022-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-03-05
First Submit QC Date:
None
Study First Post Date:
2015-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-01
Last Update Post Date:
2021-04-05
Last Update Post Date Type:
ACTUAL